HEADER LIGASE 30-DEC-08 2W7T TITLE TRYPANOSOMA BRUCEI CTPS - GLUTAMINASE DOMAIN WITH BOUND ACIVICIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE CYTIDINE TRIPHOSPHATE SYNTHASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: GLUTAMINASE DOMAIN, RESIDUES 319-589; COMPND 5 SYNONYM: CTP SYNTHETASE; COMPND 6 EC: 6.3.4.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TRYPANOSOMA BRUCEI; SOURCE 3 ORGANISM_TAXID: 5691; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_VARIANT: R3 PRARE; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PNIC-BSA4 KEYWDS GLUTAMINASE DOMAIN, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR M.WELIN,M.MOCHE,C.H.ARROWSMITH,H.BERGLUND,C.BOUNTRA,R.COLLINS, AUTHOR 2 L.G.DAHLGREN,A.M.EDWARDS,S.FLODIN,A.FLORES,S.GRASLUND,M.HAMMARSTROM, AUTHOR 3 A.JOHANSSON,I.JOHANSSON,T.KARLBERG,T.KOTENYOVA,L.LEHTIO,M.E.NILSSON, AUTHOR 4 T.NYMAN,C.PERSSON,J.SAGEMARK,H.SCHUELER,M.I.SIPONEN,A.G.THORSELL, AUTHOR 5 L.TRESAUGUES,S.VAN DEN BERG,J.WEIGELT,M.WIKSTROM,M.WISNIEWSKA, AUTHOR 6 P.NORDLUND,STRUCTURAL GENOMICS CONSORTIUM (SGC) REVDAT 6 13-DEC-23 2W7T 1 REMARK LINK REVDAT 5 24-MAY-17 2W7T 1 JRNL REVDAT 4 06-MAY-15 2W7T 1 AUTHOR JRNL REVDAT 3 04-DEC-13 2W7T 1 SOURCE KEYWDS REMARK VERSN REVDAT 3 2 1 FORMUL REVDAT 2 27-JAN-09 2W7T 1 AUTHOR JRNL REMARK MASTER REVDAT 1 13-JAN-09 2W7T 0 JRNL AUTH M.WELIN,M.MOCHE,C.H.ARROWSMITH,H.BERGLUND,C.BOUNTRA, JRNL AUTH 2 R.COLLINS,L.G.DAHLGREN,A.M.EDWARDS,S.FLODIN,A.FLORES, JRNL AUTH 3 S.GRASLUND,M.HAMMARSTROM,A.JOHANSSON,I.JOHANSSON,T.KARLBERG, JRNL AUTH 4 T.KOTENYOVA,L.LEHTIO,M.E.NILSSON,T.NYMAN,C.PERSSON, JRNL AUTH 5 J.SAGEMARK,H.SCHUELER,M.I.SIPONEN,A.G.THORSELL,L.TRESAUGUES, JRNL AUTH 6 S.VAN DEN BERG,J.WEIGELT,M.WIKSTROM,M.WISNIEWSKA,P.NORDLUND, JRNL AUTH 7 STRUCTURAL GENOMICS CONSORTIUM (SGC) JRNL TITL TRYPANOSOMA BRUCEI CTPS - GLUTAMINASE DOMAIN WITH BOUND JRNL TITL 2 ACIVICIN JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.78 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 14121 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 744 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 946 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2010 REMARK 3 BIN FREE R VALUE SET COUNT : 50 REMARK 3 BIN FREE R VALUE : 0.2910 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2072 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 2 REMARK 3 SOLVENT ATOMS : 99 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.37000 REMARK 3 B22 (A**2) : 1.11000 REMARK 3 B33 (A**2) : -0.73000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.268 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.220 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.152 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.550 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.926 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.878 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2116 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1439 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2863 ; 1.254 ; 1.949 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3473 ; 0.911 ; 3.002 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 263 ; 5.615 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 101 ;33.974 ;23.663 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 350 ;14.971 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;18.988 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 314 ; 0.073 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2381 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 449 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 412 ; 0.199 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1515 ; 0.197 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1039 ; 0.174 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1104 ; 0.094 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 98 ; 0.179 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 21 ; 0.142 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 47 ; 0.216 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 12 ; 0.216 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1427 ; 0.883 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2110 ; 1.311 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 875 ; 1.875 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 753 ; 2.844 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. ACIVICIN IS COVALENTLY BOUND TO CYS 419. REMARK 4 REMARK 4 2W7T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-DEC-08. REMARK 100 THE DEPOSITION ID IS D_1290038361. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-DEC-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98004 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL, SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14866 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 7.840 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.4 REMARK 200 DATA REDUNDANCY IN SHELL : 5.97 REMARK 200 R MERGE FOR SHELL (I) : 0.22000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 6.160 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1VCN REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.15 M POTASSIUM BROMIDE, 30 % PEG REMARK 280 MONOMETHYL ETHER 2000 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.24000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.29000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.84000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 38.29000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.24000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.84000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASN 319 TO TYR REMARK 400 ENGINEERED RESIDUE IN CHAIN A, HIS 475 TO TYR REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 317 REMARK 465 MET A 318 REMARK 465 TYR A 319 REMARK 465 MET A 320 REMARK 465 SER A 321 REMARK 465 ASN A 322 REMARK 465 PRO A 323 REMARK 465 GLN A 588 REMARK 465 ALA A 589 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 358 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 446 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE2 GLN A 423 O HOH A 2027 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 472 CB CYS A 472 SG -0.099 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 5CS A 419 -98.90 58.68 REMARK 500 ASN A 445 88.73 -150.23 REMARK 500 ARG A 498 88.66 -158.08 REMARK 500 ARG A 500 -34.65 -132.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1588 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 1589 DBREF 2W7T A 317 318 PDB 2W7T 2W7T 317 318 DBREF 2W7T A 319 589 UNP Q4GZ95 Q4GZ95_9TRYP 319 589 SEQADV 2W7T TYR A 319 UNP Q4GZ95 ASN 319 ENGINEERED MUTATION SEQADV 2W7T TYR A 475 UNP Q4GZ95 HIS 475 ENGINEERED MUTATION SEQRES 1 A 273 SER MET TYR MET SER ASN PRO THR VAL ARG ILE ALA PHE SEQRES 2 A 273 VAL GLY LYS TYR LEU GLN ASP ALA GLY ASP THR TYR PHE SEQRES 3 A 273 SER VAL LEU GLN CYS PHE GLU HIS CYS GLN ILE ALA LEU SEQRES 4 A 273 GLN VAL ARG LEU ASP ILE LEU TYR VAL ASP SER GLU GLU SEQRES 5 A 273 LEU GLU GLY PRO ASN ALA ASP GLU ALA ARG LYS ALA LEU SEQRES 6 A 273 LEU GLY CYS ASP GLY ILE PHE VAL PRO GLY GLY PHE GLY SEQRES 7 A 273 ASN ARG GLY VAL ASP GLY LYS CYS ALA ALA ALA GLN VAL SEQRES 8 A 273 ALA ARG MET ASN ASN ILE PRO TYR PHE GLY VAL 5CS LEU SEQRES 9 A 273 GLY MET GLN VAL ALA VAL ILE GLU LEU SER ARG ASN VAL SEQRES 10 A 273 VAL GLY TRP SER ASP ALA ASN SER GLU GLU PHE ASN LYS SEQRES 11 A 273 GLU SER THR HIS GLN VAL VAL ARG ILE MET ASP CYS ASP SEQRES 12 A 273 ARG ASN LYS MET GLY ALA ASN MET HIS LEU GLY ALA CYS SEQRES 13 A 273 ASP VAL TYR ILE VAL GLU LYS SER SER ILE MET ALA LYS SEQRES 14 A 273 ILE TYR SER LYS SER ASN ILE VAL VAL GLU ARG HIS ARG SEQRES 15 A 273 HIS ARG TYR GLU VAL ASN THR ALA TYR PHE GLU ASP LEU SEQRES 16 A 273 ARG LYS ALA GLY LEU CYS ILE SER ALA VAL THR ASP PRO SEQRES 17 A 273 THR PHE SER SER ARG CYS ARG VAL GLU ALA VAL GLU ASN SEQRES 18 A 273 PRO SER LEU ARG PHE PHE LEU ALA VAL GLN PHE HIS PRO SEQRES 19 A 273 GLU PHE ILE SER THR PRO MET ASP PRO ALA PRO THR TYR SEQRES 20 A 273 LEU SER PHE MET ALA ALA ALA ALA LYS LYS ASP TYR VAL SEQRES 21 A 273 TRP PRO GLN LYS CYS SER GLN ARG ARG LEU LYS GLN ALA MODRES 2W7T 5CS A 419 CYS HET 5CS A 419 16 HET CL A1588 1 HET CL A1589 1 HETNAM 5CS 2-AMINO-3-(CYSTEIN-S-YL)-ISOXAZOLIDIN-5-YL-ACETIC ACID HETNAM CL CHLORIDE ION FORMUL 1 5CS C8 H15 N3 O5 S FORMUL 2 CL 2(CL 1-) FORMUL 4 HOH *99(H2 O) HELIX 1 1 TYR A 333 GLY A 338 1 6 HELIX 2 2 TYR A 341 GLN A 356 1 16 HELIX 3 3 GLU A 367 GLU A 370 5 4 HELIX 4 4 ALA A 374 GLY A 383 1 10 HELIX 5 5 GLY A 397 ASN A 412 1 16 HELIX 6 6 LEU A 420 VAL A 433 1 14 HELIX 7 7 MET A 456 ASP A 459 5 4 HELIX 8 8 SER A 481 TYR A 487 1 7 HELIX 9 9 TYR A 507 ALA A 514 1 8 HELIX 10 10 HIS A 549 ILE A 553 5 5 HELIX 11 11 ALA A 560 LYS A 572 1 13 HELIX 12 12 SER A 582 LEU A 586 5 5 SHEET 1 AA 9 LEU A 359 ASP A 365 0 SHEET 2 AA 9 VAL A 325 GLY A 331 1 O VAL A 325 N ASP A 360 SHEET 3 AA 9 GLY A 386 VAL A 389 1 O GLY A 386 N ALA A 328 SHEET 4 AA 9 TYR A 415 GLY A 417 1 O PHE A 416 N VAL A 389 SHEET 5 AA 9 PHE A 543 VAL A 546 1 O LEU A 544 N GLY A 417 SHEET 6 AA 9 VAL A 532 GLU A 536 -1 O VAL A 535 N ALA A 545 SHEET 7 AA 9 CYS A 517 VAL A 521 -1 O CYS A 517 N GLU A 536 SHEET 8 AA 9 HIS A 468 ILE A 476 -1 O TYR A 475 N VAL A 521 SHEET 9 AA 9 ILE A 492 HIS A 499 -1 O VAL A 493 N VAL A 474 SHEET 1 AB 3 ASN A 440 SER A 441 0 SHEET 2 AB 3 GLN A 451 ARG A 454 1 N VAL A 453 O ASN A 440 SHEET 3 AB 3 GLU A 502 VAL A 503 -1 O GLU A 502 N ARG A 454 LINK C VAL A 418 N 5CS A 419 1555 1555 1.33 LINK C 5CS A 419 N LEU A 420 1555 1555 1.33 SITE 1 AC1 3 LYS A 485 ARG A 541 HOH A2089 SITE 1 AC2 5 GLY A 331 LYS A 332 SER A 366 ARG A 396 SITE 2 AC2 5 LYS A 401 CRYST1 50.480 63.680 76.580 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019810 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015704 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013058 0.00000